GIVLAARI 189 MG in 1 ML Injection

RxCUI: 2265721
RxNorm name: GIVLAARI 189 MG in 1 ML Injection
Display name: GIVLAARI 189 MG in 1 ML Injection
Full name: GIVLAARI 189 MG in 1 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GIVLAARI	GIVOSIRAN SODIUM	Alnylam Pharmaceuticals, Inc.	167e663c-11e1-497b-a3fc-951d65d58eaa	2025-09-10	Warnings, Adverse reactions	Exact identifier rxcui: 2265721

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
167e663c-11e1-497b-a3fc-951d65d58eaa	GIVLAARI 189 MG in 1 ML Injection	PSN	14	These highlights do not include all the information needed to use GIVLAARI ® safely and effectively. See full prescribing information for GIVLAARI. GIVLAARI (givosiran) injection, for subcutaneous use Initial U.S. Approval: 2019	20250910
167e663c-11e1-497b-a3fc-951d65d58eaa	1 ML Givlaari 189 MG/ML Injection	SY	14	These highlights do not include all the information needed to use GIVLAARI ® safely and effectively. See full prescribing information for GIVLAARI. GIVLAARI (givosiran) injection, for subcutaneous use Initial U.S. Approval: 2019	20250910
167e663c-11e1-497b-a3fc-951d65d58eaa	Givlaari 189 MG per 1 ML Injection	SY	14	These highlights do not include all the information needed to use GIVLAARI ® safely and effectively. See full prescribing information for GIVLAARI. GIVLAARI (givosiran) injection, for subcutaneous use Initial U.S. Approval: 2019	20250910
167e663c-11e1-497b-a3fc-951d65d58eaa	1 ML givosiran 189 MG/ML Injection [Givlaari]	SBD	14	These highlights do not include all the information needed to use GIVLAARI ® safely and effectively. See full prescribing information for GIVLAARI. GIVLAARI (givosiran) injection, for subcutaneous use Initial U.S. Approval: 2019	20250910